Analysis and Optimization of Predictive and Therapeutic Models in Uterine Neoplasms
Condition(s):Uterine NeoplasmsLast Updated:February 14, 2024Recruiting
Hide Studies Not Open or Pending
Condition(s):Uterine NeoplasmsLast Updated:February 14, 2024Recruiting
Condition(s):Uterine CancerLast Updated:September 15, 2023Recruiting
Condition(s):Uterine CancerLast Updated:December 5, 2023Completed
Condition(s):Uterine CancerLast Updated:August 21, 2023Not yet recruiting
Condition(s):Uterine CancersLast Updated:November 6, 2011Unknown status
Condition(s):Uterine CancerLast Updated:April 24, 2012Terminated
Condition(s):Uterine Cervical Cancer; Diffusion-weighted MRI; RecurrenceLast Updated:December 2, 2015Unknown status
Condition(s):Endometrial Carcinoma; Malignant Uterine Neoplasm; Uterine Corpus Cancer; Uterine Corpus SarcomaLast Updated:December 11, 2023Active, not recruiting
Condition(s):Ovarian Neoplasms; Uterine NeoplasmsLast Updated:April 24, 2012Completed
Condition(s):Uterine CancerLast Updated:June 30, 2020Withdrawn
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.